← Eichor
Study identifier: NCT03594344 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Additional Hyperbaric Oxygen After Lower Extremity Amputation

Condition: Diabetes Mellitus · Claudication, Intermittent · Critical Limb Ischemia  ·  Sponsor: Oslo University Hospital

PhaseNA
Planned participants120
Who can joinAll sexes, 18 Years to 90 Years
Healthy volunteersNo

About this study

This study evaluates the effect of additional hyperbaric oxygen therapy after lower extremity amputation. The patients will be randomized after amputation to either a treatment group receiving hyperbaric oxygen therapy, or control group.

This description comes directly from the study's public registry record.

Talk to the study team

Jonas Rydinge, MD  ·  +4792291795  ·  jonryd@ous-hf.no

Elisabeth I Ellingsen Husebye, MD, PhD  ·  +47 95133773  ·  uxngng@ous-hf.no

Always discuss trial participation with your own doctor first.

Locations (2)

Diakonhjemmet HospitalOslo, NorwayRecruiting
Orthopedic Center, Ullevål University HopspitalOslo, NorwayRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT03594344